Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02651467 · ClinicalTrials.gov registry record · NA

A Study to Investigate Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Pain Derived From Exposed Dentine in Response to Chemical, Thermal, Tactile, or Osmotic Stimuli.

A NA study, sponsored by GlaxoSmithKline.

Completed
Registry status
NA
Development phase
221
Enrollment target

NCT02651467: Completed NA study, sponsored by GlaxoSmithKline.

NCT02651467 is a NA study that has completed, run by GlaxoSmithKline. The registered enrollment target is 221 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02651467, a NA study, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
NA
Development phase
221 participants
Enrollment target

Study Summary

This will be a single center, eight week, randomized, double blind, three treatment arm, parallel design, stratified (by mean baseline Schiff Sensitivity Score of the two selected test teeth) study in healthy participants.

Primary Outcome

Schiff sensitivity score was assessed by participant's response to an evaporative (air) stimulus after the stimulation of each individual tooth, response of participant was scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3= Participant responds to stimulus, consid

Interventions

  • OTHER Experimental Oral Rinse 1 (1.5% w/w KOX, 0ppm F, pH 7.0)
  • OTHER Experimental Oral Rinse 2 (2.0% w/w KOX, 45ppm F, pH 4.5)
  • OTHER Placebo Oral Rinse (0% w/w KOX 0ppm F, pH 4.5 )

Trial Details

FieldValue
Enrollment Target 221 participants
Start Date 2016-01-04
Est. Completion 2016-04-22
Phase NA
GlaxoSmithKline

1,345 total trials

What the finished NCT02651467 record still lists

NCT02651467 is an interventional study that assigns participants to a tested intervention. The registered 221 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 3 interventions - of which Experimental Oral Rinse 1 (1.5% w/w KOX, 0ppm F, pH 7.0) is the first listed.

NCT02651467 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02651467 about?

NCT02651467 is a clinical study titled "A Study to Investigate Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Pain Derived From Exposed Dentine in Response to Chemical, Thermal, Tactile, or Osmotic Stimuli.". This will be a single center, eight week, randomized, double blind, three treatment arm, parallel design, stratified (by mean baseline Schiff Sensitivity Score of the two selected test teeth) study in healthy participants.

What is the current status of trial NCT02651467?

This trial is currently completed. It is a NA study. The enrollment target is 221 participants. The study started on 2016-01-04. Estimated completion is 2016-04-22.

What interventions are being tested in trial NCT02651467?

The interventions under investigation include: Experimental Oral Rinse 1 (1.5% w/w KOX, 0ppm F, pH 7.0) (OTHER), Experimental Oral Rinse 2 (2.0% w/w KOX, 45ppm F, pH 4.5) (OTHER), Placebo Oral Rinse (0% w/w KOX 0ppm F, pH 4.5 ) (OTHER).

Who is sponsoring clinical trial NCT02651467?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02651467's enrollment target sits among peer trials

221 481st of 2000 higher than 1,520 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03170440 · 221 participants · NA

    Non-invasive Nerve Stimulation for PTSD and Sleep

  • NCT04939610 · 222 participants · Phase 1

    A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

  • NCT05424783 · 222 participants

    MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)

  • NCT05568264 · 222 participants · NA

    Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02651467, the US trial registry maintained by the National Library of Medicine. NCT02651467 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.